"If this happens it will be a blow to the common man as prices of medicines will spike and become unaffordable for the public," Swadeshi Jagran Manch National co-convenor Ashwani Mahajan claimed.
Mahajan also wrote to Chemicals and Fertiliser Minister Ananth Kumar, alleging the NITI Aayog is "fully occupied with the interests of private players, and is hand in gloves with the Department of Pharmaceuticals".
"... That is why it (NITI Aayog) is aggressively pushing privatisation of public health care as well as attempting to decontrol pricing of essential medicines," Mahajan said in a letter.
"We have learnt that the DOP along with NITI Aayog, is planning to amend the drug price control order (DPCO) 2013 and that this exercise is in advanced stages whereby several amendments are being finalised..," he added.
The SJM further said Prime Minister Narendra Modi wants to ensure that the poor in the country get essential medicines at reasonable and affordable prices.
"But, unfortunately, departments in Modi government are acting against what he had promised to the people," Mahajan added.
He has requested Chemicals and Fertiliser Minister Kumar's to intervene and "stem the attempts to undermine the independence" of the NPPA and its ability to act in public interest.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
